---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004120"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:00:45.846067+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# All Series A Warrants exercised by holders as of June 11, 2024

## Summary
- Series A Warrants issued on Feb 15, 2024 fully exercised as of June 11, 2024.
- No details on number of warrants, exercise price, or total proceeds provided.
- Exercise may result in dilution but share count impact not disclosed.
- Company did not specify use of proceeds from the warrant exercises.

## SEC filing metadata
- accession: 0001683168-24-004120
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004120/0001683168-24-004120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824004120/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004120
- JSON: https://secwatch.observer/filing/0001683168-24-004120.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.